Neuromyelitis Optica Spectrum Disorder - 28 Studies Found
Active, not recruiting |
: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders :
|
Active, not recruiting |
: A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD :
|
Active, not recruiting |
: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica :
: 2011-05-31 : Biological: human umbilical cord mesenchymal stem cells Participants will be given hUC-MSCs transplantat |
Recruiting |
: A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis :
|
Recruiting |
: Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct :
: 2009-12-02 |
NOT_YET_RECRUITING |
: Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA� During Pregnancy : : 2024-05-17 : Enrolled female participants with NMOSD who were exposed to UPLIZNA during pregnancy will be assessed.No study drug will be administered. |
NOT_YET_RECRUITING |
: Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders : : 2024-05-17 : Inebilizumab: 300mg IV on Day1 and Day 15.The first dose of inelizumab is given during IVMP. |
RECRUITING |
: Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA� During Pregnancy : Neuromyelitis Optica Spectrum Disorder : 2024-05-17 : Enrolled female participants with NMOSD who were exposed to UPLIZNA during pregnancy will be assessed.No study drug will be administered. |